Articles

stable ischemic heart disease American College of Cardiology (ACC)

Ischemic heart disease affects nearly 10 million Americans, and remains the leading cause of death among U.S. adults. This condition is most often due to a build-up of fat or plaque in the heart’s...

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has revolutionized the imaging world...

Avinger Ocelot OCT CTO catheter

The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross...

Cook, Zilver PTX, stent

The U.S. Food and Drug Administration (FDA) granted market clearance for Cook Medical’s Zilver PTX drug-eluting peripheral stent. It is the first device of its kind on several fronts to go...

November 12, 2012 — Abiomed Inc. said it received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for the use of the new Impella RP (right-side...

Boston Scientific Clinical Trial Implantable Cardioverter Defibrillator

November 12, 2012 — Boston Scientific Corp. and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce...

Amplatzer Structural Heart Occulder Closure Device RESPECT Clinical Trial

November 8, 2012 — Results of the RESPECT clinical trial, presented at TCT 2012, indicates that using an investigational...

Clinical Study Catherization Kindey Damage Contrast Media

November 8, 2012 — A hydration regimen tailored to the patient’s fluid status was effective in reducing damage to kidneys in patients undergoing cardiac catheterization, according to a study...

FDA Intra-Aortic Balloon Pumps

November 8, 2012 — A U.S. Food and Drug Administration (FDA) advisory committee is meeting Dec. 5 to discuss how to classify and regulate...

Boston Scientific Renal Denervation Vessix Vascular

November 8, 2012 — Boston Scientific Corp. is extending its reach into the renal denervation market by signing a...